RFA-HG-25-009: Supporting Talented Early Career Researchers in Genomics (R01)

RFA-HG-25-009: Supporting Talented Early Career Researchers in Genomics (R01)

Key details

What this opportunity is and why it is relevant for 2026/2027

This NOFO is not a passive funding call; it is an active, recurring NIH round designed to support early-career investigators launching independent genomics programs. In practical terms, this is a high-leverage opportunity if you are at the point where you can run a full research project, but you still need portfolio-supporting funding to establish sustainability, visibility, and a distinct research direction.

Because it is NHGRI-focused and explicitly labeled as an RFA (Request for Applications), it is a competitive, mission-specific track rather than a broad unrestricted grant. The language around 2024 and 2025 updates and the listed annual application rounds signals that teams need to monitor the page each cycle for timing and potential policy edits. The page remains the governing source for 2026 and 2027, with application due dates listed in those years.

This page is especially relevant for these reasons:

• It is explicitly for genomics, including genomic medicine, genomic data science, and ELSI work connected to genomic research.
• It targets candidates in early independent career stages, which matches a gap between postdoctoral training and full senior funding.
• It combines scientific merit criteria with explicit career-development requirements, so it rewards clear leadership planning, not just a strong experiment.
• It has recurring due dates, creating multiple entry points for teams whose timeline misses one cycle.

The opportunity is strong for applicants in U.S. academic and nonprofit research ecosystems who can produce a coherent five-year plan and institutional support letters.

Scope, mission fit, and likely ideal applicants

The program description is clear that projects should advance NHGRI priorities broadly:

• genomics resources and methods,
• implementation of genomic medicine,
• genomic data science and bioinformatics,
• ethical, legal, and social implications of genomics.

Examples outside the mission are explicitly discouraged, including narrow locus-focused studies and narrow disease-only projects that do not align with NHGRI’s cross-cutting mission framing. While this seems strict, it is exactly why strong fit on strategic goals matters.

Who it is built for

The right applicants tend to meet all of the following profile points:

• ESI status at application in NIH records, correctly reflected in eRA Commons.
• Independent role and institutional standing, typically tenure track or equivalent (commonly assistant level or research assistant professor-equivalent).
• A research idea with a clear genomics anchor and an articulated roadmap for independent innovation.
• Ability to define advisory committee expectations and a professional/scientific development plan (required).
• Access to basic institutional commitment that can be documented in a chair letter (space, startup, protected time, etc.).

Who should not apply

The NOFO is explicit that this is not a mentor-led entry route:

• Researchers still in mentored status (for example postdocs) are not eligible as PD/PIs.
• Foreign (non-domestic) organizations cannot apply as prime recipients.
• Multiple PD/PIs are not accepted due to the career-advancement framing.
• Applications without required development-planning elements can be rejected as non-responsive before peer review.

If your current profile is closer to training stage than independent PI stage, this is a poor fit for now.

Eligibility and organizational requirements in concrete terms

The NOFO makes two critical separations that applicants often blur:

1. Eligible PI status versus eligible applicant organization.
2. Programmatic mission fit versus administrative compliance.

PI-level requirements

The PD/PI must be an NIH-defined Early Stage Investigator in eRA Commons at submission time. The record should be accurate before review, because non-compliance risks administrative rejection.

The PI should be independent, with dedicated independent lab space or access to equivalent resources. The program also asks for at least 3 person-months (25%) effort yearly from the recipient PI on activities supported by the award.

The page also warns that a pending competing award can remove ESI status depending on NIH policy, so timing between simultaneous applications matters.

Organization-level requirements

Eligible organizations are broad within the U.S. public ecosystem: higher education, nonprofits, small and non-small for-profits, governments, federal agencies, and some community organizations. But the opportunity is explicit that foreign organizations are not eligible as prime applicants. U.S. territory/possession organizations are included.

Registrations: required before submission

You must have completed mandatory registrations before the due date, including SAM/eRA/Grants.gov pathways as applicable. This is not optional prep: failure to register in time is not accepted as an excuse for late or broken submissions.

Money, budget structure, and what “$400,000/year” really means

The page provides a direct budget guardrail: maximum $400,000 direct costs per project year. A practical reading is that NHGRI expects a robust but bounded R01 plan where every line item is justified and tied to research activity plus required development components.

This NOFO does not require cost sharing.

Additional useful cost planning points:

• Plan for travel funding to the NHGRI annual meeting up to $1,500 direct per year as allowed in budget.
• Include realistic costs for face-to-face Advisory Committee meetings if that is built into the development plan.
• Keep staffing and project design consistent with five-year max duration.

The NOFO includes older language describing intended commitments and an approximate award count historically tied to appropriations. Treat that as context, not a guaranteed quota for the next rounds.

Timeline and deadlines to track (including 2026/2027)

The opportunity page lists a posted and open date sequence and annual cycles. The relevant high-value dates are:

• Posted and open date in late 2024/early 2025 context (use current posted version on NIH as authoritative).
• Round dates in the table include entries with due dates in 2026-02-27 and 2027-02-26 (local applicant-time, with 5:00 PM local time rule).
• The page also states expiration date around 2027-02-27, reinforcing that the 2027 cycle is the current listed end of this notice cycle.

Important operationally:

• No late applications are accepted.
• If a date falls on weekend/holiday, NIH submission platforms may move to next business day, but do not rely on this as a cushion.
• The NOFO explicitly encourages early submission because NIH systems can flag errors that are easier to fix before deadline.

Because the task explicitly targets opportunities useful for 2026 and 2027, this notice is aligned with that target as it publishes the recurring review and award calendar.

Application workflow and required materials

The core workflow is standard NIH e-submission with NOFO-specific required elements.

Submission options

Applicants can submit through:

• NIH ASSIST,
• Institutional system-to-system (S2S) with Grants.gov plus eRA tracking,
• Grants.gov Workspace plus eRA Commons.

Required core components

At minimum, expect these items to be fully built and compliant:

1. All materials required by NIH Research (R) instructions.
2. Two-page Professional and Scientific Development Plan (strictly required in this NOFO).
3. Advisory Committee plan with role description and expected career-development impact.
4. Detailed Research Plan and Strategy emphasizing innovation, feasibility, and genomics relevance.
5. Department chair letter describing institutional commitment and resources.
6. Data Management and Sharing Plan and Resource Sharing Plan (non-optional for NIH submissions, especially genomics-heavy work).
7. Mentor role/independence statements where relevant and former mentor still at institution.

Required registration prerequisites

Before submission, ensure:

• SAM registration (with UEI/CAGE where relevant),
• eRA Commons accounts for Signing Official and PD/PI,
• Grants.gov registration,
• accurate organization identifiers.

The systems piece is often the failure point for technically eligible applications, so this should be locked early.

Evaluation expectations and how applications are screened

The process follows NIH peer review with overall impact weighted heavily. For this opportunity, review quality is tied to two layers:

• The standard scored factors for significance/innovation and approach/feasibility.
• The opportunity-specific requirement that applicants demonstrate a realistic, high-quality plan for independent development through advisory engagement.

Practical interpretation:

• A technically strong project but weak career-development structure may fail response checks.
• Applications can still be downgraded if the project is considered out of mission scope.
• If mandatory elements are missing (for example, development plan), applications may be withdrawn before review.

Practical readiness checklist: making this NOFO application review-ready

1) Lock ESI status and role definitions first

Before drafting, verify eRA records. If ESI status is missing, update degree records early. This is not a cosmetic field; it is a gating item.

2) Build a five-page narrative strategy around a genomics thesis

Focus research text on a clear problem framed as a genomics opportunity with a coherent 5-year logic. Keep scope realistic and tied to the budget cap. Avoid framing the proposal as too broad or too narrow for genomics priorities.

3) Write the development plan as a program component, not a formality

The development plan should be concrete:

• annual advisory cadence,
• training and career activities,
• how external feedback changes research direction,
• how mentorship and independence are balanced,
• measurable milestones over 60 months.

4) Obtain institutional letters early

The department chair letter is not optional. If a previous mentor remains in the same institution, that supporting letter should be explicitly aligned to PI independence.

5) Pre-flight your technical checklist

Run through page-limit and component checks before submission:

• budgets aligned with caps,
• required forms complete,
• data management and sharing section present and coherent,
• no missing person IDs,
• all registries completed and validated by administrative staff.

Common mistakes and how to prevent them

1. Assuming this is a general junior PI grant for any field

   • Prevention: Explicitly map each specific aim to NHGRI mission language and show why the work is genomics-relevant.

2. Forgetting the professional development plan

   • Prevention: include the two-page plan as a standalone required module with committee structure and activities.

3. Submitting with unstable registration or missing credential IDs

   • Prevention: do registrations before protocol drafting is done and verify before final assembly.

4. Mentor-heavy PI structure without independence language

   • Prevention: explain your own scientific direction, avoid presenting mentor-led duplication, and separate mentor roles clearly.

5. Ignoring duplicate/overlapping submission rules

   • Prevention: monitor internal pipeline, avoid parallel highly overlapping R01s, and confirm that related submissions do not create automatic administrative conflicts.

6. Assuming broad international eligibility

   • Prevention: ensure the applicant organization is eligible under U.S.-entity rules.

7. Underestimating timing

   • Prevention: target submission at least a week before the due date for error correction cycles.

FAQs for planners targeting 2026/2027 cycles

Is this only for students or postdocs?

No. Postdocs in mentored status are explicitly out. The call is for newly independent talent at ESI stage and suitable faculty-like appointments.

Is this funding only for clinical genomics?

No. Clinical trials are optional, and sequencing work can include broad genomics and data-science pathways as long as they are mission-aligned.

Can foreign applicants apply?

Non-domestic organizations are not eligible to apply. Non-domestic components of U.S. organizations can be part of U.S. structures where allowed by NIH definitions.

What amount can we request?

The NOFO states a direct-cost cap at $400,000 per year and a maximum project period of five years.

Is cost sharing mandatory?

No.

What happens if I miss the due date by hours?

Late applications are rejected. If a changed/corrected submission is needed, it still must be received by the deadline.

Official links and authoritative navigation

For planning and execution, use the direct official NOFO page first and the required NIH application guides it references. Keep the page open while drafting because notice-specific updates can change formatting and requirements.

• Main NOFO: https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-25-009.html
• Grants management and application process references are linked from the NOFO’s own sections.
• eRA Commons / Grants.gov / SAM registrations are all part of the pre-submission path.

Bottom-line guidance

This is a high-standards opportunity built for ESI researchers who can combine scientific novelty with an explicit career trajectory. Its strength is not only the budget; it is the combined requirement to propose excellent science plus a concrete development architecture around advisory governance and independence.

If you are on a 2026 or 2027 timeline, monitor the NOFO page for final notices, then work backward: register early, draft the development plan first, assemble letters, and only then finalize the scientific package. The recurring cycle gives additional chances, but the administrative and compliance load remains strict for each round.